Revelation Biosciences, Inc. - ROE
REVB
Price:
$0.98
Market Cap:
$3.83M
Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.
Industry
Biotechnology
IPO Date
2020-11-17
Stock Exchange
NASDAQ
Ticker
REVB
PE Ratio
[-0.77]
ROE
[-107.66%]
Current Ratio
[10.02]
Dividend Yield
[0%]
Enterprise Value
[-9524119.00]
Dividend History
The ROE as of June 2026 (TTM) for Revelation Biosciences, Inc. (REVB) is -107.66%
According to Revelation Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -107.66%. This represents a change of 224.44% compared to the average of -33.18% of the last 4 quarters.
Revelation Biosciences, Inc. (REVB) Historical ROE (quarterly & annually)
How has REVB ROE performed in the past?
The mean historical ROE of Revelation Biosciences, Inc. over the last ten years is 1.52%. The current -107.66% ROE has changed -107.07% with respect to the historical average. Over the past ten years (40 quarters), REVB's ROE was at its highest in in the March 2022 quarter at 6.72%. The ROE was at its lowest in in the June 2024 quarter at -735.68%.
Average
1.52%
Median
-47.79%
Minimum
-1028.98%
Maximum
12.05%
Revelation Biosciences, Inc. (REVB) ROE by Quarter and Year
Discovering the peaks and valleys of Revelation Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 17.56%
Maximum Annual ROE = 12.05%
Minimum Annual Increase = -25314.64%
Minimum Annual ROE = -1028.98%
| Year | ROE | Change |
|---|---|---|
| 2025 | -100.59% | -68.51% |
| 2024 | -319.40% | 17.56% |
| 2023 | -1.81% | -99.82% |
| 2022 | -1028.98% | -108.54% |
| 2021 | 12.05% | -25314.64% |
| 2020 | -47.79% | -147.79% |
Revelation Biosciences, Inc. (REVB) Average ROE
How has REVB ROE performed in the past?
The current ROE of Revelation Biosciences, Inc. (REVB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-140.60%
5-year avg
2.12%
10-year avg
1.52%
Revelation Biosciences, Inc. (REVB) ROE vs. Peers
How is REVB’s ROE compared to its peers?
Revelation Biosciences, Inc.’s ROE is greater than SciSparc Ltd. (-704.60%), greater than Onconetix, Inc. (-105.46%), greater than Indaptus Therapeutics, Inc. (-1028.81%), greater than GT Biopharma, Inc. (-901.32%), greater than Salarius Pharmaceuticals, Inc. (-395.42%), less than NKGen Biotech, Inc. Common Stock (55.88%), greater than Avenue Therapeutics, Inc. (-65.83%), greater than Psyence Biomedical Ltd. (-47.61%), greater than Azitra, Inc. (-251.51%), greater than Silexion Therapeutics Ltd. (-516.87%),
| Company | ROE | Market cap |
|---|---|---|
| -704.60% | $428.59K | |
| -105.46% | $315.29K | |
| -1028.81% | $6.83M | |
| -901.32% | $5.46M | |
| -395.42% | $4.92M | |
| 55.88% | $7.84M | |
| -65.83% | $1.07M | |
| -47.61% | $59.91K | |
| -251.51% | $1.84M | |
| -516.87% | $1.14M |
Build a custom stock screener for Revelation Biosciences, Inc. (REVB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revelation Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Revelation Biosciences, Inc. (REVB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Revelation Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Revelation Biosciences, Inc.'s ROE?
How is the ROE calculated for Revelation Biosciences, Inc. (REVB)?
What is the highest ROE for Revelation Biosciences, Inc. (REVB)?
What is the 3-year average ROE for Revelation Biosciences, Inc. (REVB)?
What is the 5-year average ROE for Revelation Biosciences, Inc. (REVB)?
How does the current ROE for Revelation Biosciences, Inc. (REVB) compare to its historical average?